SOLUBLE ST2 AND CD163 AS POTENTIALBIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME. (2019). Mediterranean Journal of Hematology and Infectious Diseases, 11(1), e2019008. https://doi.org/10.4084/mjhid.2019.008